欢迎来到天天文库
浏览记录
ID:34305951
大小:1.82 MB
页数:41页
时间:2019-03-05
《家蝇抗真菌肽maf-1a大鼠药代动力学初探》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、贵阳医学院2013届硕士研究生论文《中国图书资料分类法》分类号:R384单位代码:10660学号:S090036贵阳医学院2013届硕士学位论文家蝇抗真菌肽MAF-1A大鼠药代动力学初探研究生:杨华导师:吴建伟教授年级:研2009级专业:病原生物学2013年5月22日贵阳医学院2013届硕士研究生论文1目录摘要„„„„„„„„„„„„„„„„„„„„„„„„2前言„„„„„„„„„„„„„„„„„„„„„„„„4材料与方法„„„„„„„„„„„„„„„„„„„„„„6结果„„„„„„„„„„„„„„„„„„„„„„
2、„„10讨论„„„„„„„„„„„„„„„„„„„„„„„„19参考文献„„„„„„„„„„„„„„„„„„„„„„„23英文摘要„„„„„„„„„„„„„„„„„„„„„„„25致谢„„„„„„„„„„„„„„„„„„„„„„„„27略缩词表„„„„„„„„„„„„„„„„„„„„„„„28论文原创性声明„„„„„„„„„„„„„„„„„„„„29附:综述„„„„„„„„„„„„„„„„„„„„„„302贵阳医学院2013届硕士研究生论文家蝇抗真菌肽MAF-1A大鼠药代动力学初探病原生物学研究生:杨华导师:吴建伟
3、摘要目的:MAF-1A大鼠药代药动力学及影响因素初步研究。方法:1、建立血清MAF-1A高效液相(HPLC)测定法,验证方法稳定性。2、药代动力学分析:Wistar大鼠15只,随机分为三组,每组经尾静脉注射MAF-1A5mg/kg(低剂量组),10mg/kg(中剂量组),20mg/kg(高剂量组)。分别于给药后5,10,20,30,60min断尾取血,进行HPLC血清MAF-1A含量分析。用[1]药动学PKSolver软件对数据进行自动拟合处理,药代动力学各项参数计算采用(非房室模型)统计矩参数计算。3、血液中MA
4、F-1A稳定性分析:取大鼠血清,血浆和全血,分别加入1μg/ml(低剂量),5μg/ml(中剂量),25μg/ml(高剂量)MAF-1A混匀,5,10,20,30,60min后经处理样本进行HPLC分析,每个时间点5个质控样本。结果:(1)本实验中MAF-1A的HPLC测量法稳定性好;线性方程为y=0.1999x-0.0107(r=0.9975);高、中、低三种不同浓度样本的精确度<15%,回收率96.59±5.38%,样品稳定性>94%。(2)血清MAF-1A主要药代学参数:低浓度组t1/2=15±2min,MR
5、T=16±2min,Cl=0.16±0.05(μg)/(μg/ml)/min;中浓度组t1/2=15±5min,MRT=15±4min,Cl=0.15±0.05(μg)/(μg/ml)/min。高浓度组t1/2=18±10min,MRT=14±2min,Cl=0.12±0.03(μg)/(μg/ml)/min。三个剂量组的药代学参数无统计学差异(P>0.05)。(3)MAF-1A血液稳定性:血清稳定性,低浓度组t1/2=26±3min,MRT=37±2min,中浓度组t1/2=48±14min,MRT=68±19m
6、in,高浓度组t1/2=48±7min,MRT=50±10min;血浆低浓度组t1/2=32±贵阳医学院2013届硕士研究生论文35min,MRT=45±6min,中浓度组t1/2=44±5min,MRT=62±9min,高浓度组t1/2=50±16min,MRT=72±17min;全血低浓度组t1/2=59±10min,MRT=86±13min,中浓度组t1/2=50±12min,MRT=73±19min,高浓度组t1/2=50±11min,MRT=78±11min。血清和血浆中不同MAF-1A浓度之间差异,以及
7、低剂量的三种样本之间差异具有统计学意义(P<0.05),中浓度和高浓度三种样本差异,以及全血不同MAF-1A浓度差异不具有统计学意义(P>0.05)。结论:MAF-1A大鼠尾静脉给药后,半衰期15min,影响因素初步分析得血清中蛋白酶可以降解MAF-1A,纤维蛋白原及血细胞对其不吸附。肝脏药物代谢酶的生物转化作用是MAF-1A的代谢途径之一。MAF-1A的HPLC测量法专属性及稳定性好,能够用于其药代动力学研究。关键词:抗菌肽、药物代谢动力学、HPLC贵阳医学院2013届硕士研究生论文4前言传统抗生素造成耐药株不断
8、地产生,寻求新的抗菌药物迫在眉睫。抗菌肽作为生物体的重要免疫分子,具有可以避免病原体的耐药性及广谱的抗菌活性的特点而倍受青睐。细菌、真菌、植物和动物都能产生序列和结构各异的抗菌肽。其具有高效、[2][3]选择毒性、稳定及不易产生抗药等特点。研究表明抗菌肽还具有抗肿瘤;免[4][5]疫调节和抗病毒作用。由于抗菌肽所特有的优越性,越来越多的抗菌肽被开发或正在开发
此文档下载收益归作者所有